Protein tyrosine phosphatase-1B is a well-characterized tyrosine phosphatase (Feldhammer et al., 2013), which has been shown to suppress both insulin and leptin signaling pathways and is therefore useful in the treatment of type II diabetes and obesity (Maheshwari et al., 2018). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.